{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T13:50:45Z","timestamp":1785937845203,"version":"3.56.0"},"reference-count":46,"publisher":"CSIRO Publishing","issue":"5","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":323,"URL":"https:\/\/doi.org\/10.1071\/journalslicense"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Parkinson\u2019s disease (PD) is one of the most prevalent neurodegenerative disorders, globally affecting approximately 120 per 100,000 people by age 70. Deep brain stimulation (DBS) is a US Federal Drug Administration (FDA)-approved and highly effective treatment for late-stage PD. However, country-specific reimbursement regulations and health policies may affect access to PD-DBS. We aimed to evaluate the uptake rate and \u2018treatment gap\u2019 for DBS across high-income countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We reviewed previous literature to investigate the cost and utilisation of PD-DBS in high-income countries across Asia, Europe, Oceania, and North America (Australia, Canada, France, Germany, Hong Kong, Japan, Korea, the Netherlands, New Zealand, Norway, Spain, Switzerland, UK, and USA). Using previous estimates of DBS candidate eligibility rates, we calculated theoretical DBS uptake rates and treatment gaps nationally.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>PD-DBS utilisation was highest in Australia and the USA and lowest in Korea and New Zealand. The total cost of PD-DBS in the first 12\u00a0months was highest in the USA and France and lowest in the UK and Germany. The utilisation rate (i.e. uptake rate) of PD-DBS (% DBS surgeries per PD case) was highest in Australia and the USA, and lowest in New Zealand and the UK, where the treatment gap reflected these trends.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results highlight differences in access to DBS for PD patients among high-income countries, which we discuss in the context of health systems. Better access to effective PD treatments such as DBS is critical given the increasing prevalence of PD in an ageing world and the associated, avoidable morbidity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1071\/ah24036","type":"journal-article","created":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T20:22:32Z","timestamp":1726431752000},"page":"497-505","source":"Crossref","is-referenced-by-count":5,"title":["The treatment gap for deep brain stimulation in Parkinson\u2019s disease: a comparative analysis of cost and utilisation in high-income countries"],"prefix":"10.1071","volume":"48","author":[{"given":"Athena","family":"Stein","sequence":"first","affiliation":[{"name":"ASchool of Public Health, The University of Queensland, Herston, Qld, Australia."},{"name":"BThe University of Queensland Child Health Research Centre, South Brisbane, Qld, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Higgins","sequence":"additional","affiliation":[{"name":"CThe Turner Institute for Brain and Mental Health and Monash Biomedical Imaging, Monash University, Clayton, Vic, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7195-6822","authenticated-orcid":true,"given":"Mehul","family":"Gajwani","sequence":"additional","affiliation":[{"name":"CThe Turner Institute for Brain and Mental Health and Monash Biomedical Imaging, Monash University, Clayton, Vic, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian A.","family":"Gericke","sequence":"additional","affiliation":[{"name":"ASchool of Public Health, The University of Queensland, Herston, Qld, Australia."},{"name":"DSchool of Medicine and Public Health, The University of Newcastle, Callaghan, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"67","published-online":{"date-parts":[[2024,9,16]]},"reference":[{"key":"2025121501355960000_R1","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/mds.25407","article-title":"Cost-effectiveness of deep brain stimulation in patients with Parkinson\u2019s disease.","volume":"28","author":"Dams","year":"2013","journal-title":"Mov Disord"},{"key":"2025121501355960000_R2","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s disease: Mechanisms and models.","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"2025121501355960000_R3","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1503\/cmaj.151179","article-title":"An update on the diagnosis and treatment of Parkinson\u2019s disease.","volume":"188","author":"Rizek","year":"2016","journal-title":"CMAJ"},{"key":"2025121501355960000_R4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2741\/s415","article-title":"Parkinson\u2019s disease: a review.","volume":"6","author":"Beitz","year":"2014","journal-title":"Front Biosci"},{"key":"2025121501355960000_R5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/mds.10391","article-title":"Reliability of reported age at onset for Parkinson\u2019s disease.","volume":"18","author":"Reider","year":"2003","journal-title":"Mov Disord"},{"key":"2025121501355960000_R6","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1002\/mds.25898","article-title":"Mortality in Parkinson\u2019s disease: a systematic review and meta-analysis.","volume":"29","author":"Macleod","year":"2014","journal-title":"Move Disord"},{"key":"2025121501355960000_R7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s12264-012-1050-z","article-title":"Progression of motor symptoms in Parkinson\u2019s disease.","volume":"28","author":"Xia","year":"2012","journal-title":"Neurosci Bull"},{"key":"2025121501355960000_R8","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.disamonth.2007.05.002","article-title":"Current pharmacotherapeutic treatment options in Parkinson\u2019s disease.","volume":"53","author":"Rezak","year":"2007","journal-title":"Dis Mon"},{"key":"2025121501355960000_R9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093524","article-title":"Coordinate-based lead location does not predict Parkinson\u2019s disease deep brain stimulation outcome.","volume":"9","author":"Nestor","year":"2014","journal-title":"PLoS One"},{"key":"2025121501355960000_R10","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.conb.2003.11.001","article-title":"Deep brain stimulation for Parkinson\u2019s disease.","volume":"13","author":"Benabid","year":"2003","journal-title":"Curr Opin Neurobiol"},{"key":"2025121501355960000_R11","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1056\/NEJMoa000827","article-title":"Deep brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson\u2019s disease.","volume":"345","author":"Deep-Brain Stimulation for Parkinson\u2019s Disease Study Group.","year":"2001","journal-title":"N Engl J Med"},{"key":"2025121501355960000_R12","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.nbd.2009.11.019","article-title":"Deep brain stimulation for movement disorders.","volume":"38","author":"Collins","year":"2010","journal-title":"Neurobiol Dis"},{"key":"2025121501355960000_R13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41380-020-00933-x","article-title":"Deep brain stimulation for refractory obsessive-compulsive disorder (OCD): emerging or established therapy?","volume":"26","author":"Wu","year":"2021","journal-title":"Mol Psychiatry"},{"key":"2025121501355960000_R14","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1177\/0004867415598011","article-title":"Deep brain stimulation in mental health: Review of evidence for clinical efficacy.","volume":"49","author":"Fitzgerald","year":"2015","journal-title":"Aust N Z J Psychiatry"},{"key":"2025121501355960000_R15","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.3233\/JPD-179007","article-title":"My 25 stimulating years with DBS in Parkinson\u2019s disease.","volume":"7","author":"Hariz","year":"2017","journal-title":"J Parkinsons Dis"},{"key":"2025121501355960000_R16"},{"key":"2025121501355960000_R17","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1056\/NEJM199810153391603","article-title":"Electrical stimulation of the subthalamic nucleus in advanced Parkinson\u2019s disease.","volume":"339","author":"Limousin","year":"1998","journal-title":"N Engl J Med"},{"key":"2025121501355960000_R18","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/jnnp.2004.047001","article-title":"Functional improvement after subthalamic stimulation in Parkinson\u2019s disease: a non-equivalent controlled study with 12-24 month follow up.","volume":"76","author":"Capecci","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2025121501355960000_R19","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.parkreldis.2006.12.013","article-title":"How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a questionnaire.","volume":"13","author":"Morgante","year":"2007","journal-title":"Parkinsonism Relat Disord"},{"key":"2025121501355960000_R20"},{"key":"2025121501355960000_R21","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.jval.2019.03.021","article-title":"Adjusting for inflation and currency changes within health economic studies.","volume":"22","author":"Turner","year":"2019","journal-title":"Value Health"},{"key":"2025121501355960000_R22","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2022.1783","article-title":"Six Action Steps to Address Global Disparities in Parkinson Disease: A World Health Organization Priority.","volume":"79","author":"Schiess","year":"2022","journal-title":"JAMA Neurol"},{"key":"2025121501355960000_R23","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2021.644593","article-title":"Proceedings of the eighth annual deep brain stimulation think tank: advances in optogenetics, ethical issues affecting DBS research, neuromodulatory approaches for depression, adaptive neurostimulation, and emerging DBS technologies.","volume":"15","author":"Vedam-Mai","year":"2021","journal-title":"Front Hum Neurosci"},{"key":"2025121501355960000_R24","doi-asserted-by":"publisher","DOI":"10.1001\/jama.305.7.732","article-title":"Deep brain stimulation.","volume":"305","author":"Pluta","year":"2011","journal-title":"JAMA"},{"key":"2025121501355960000_R25","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1002\/mds.10149","article-title":"Deep brain stimulation for Parkinson\u2019s disease: Patient selection and evaluation.","volume":"17","author":"Lang","year":"2002","journal-title":"Mov Disord"},{"key":"2025121501355960000_R26","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016.","volume":"17","author":"GBD 2016 Parkinson\u2019s Disease Collaborators.","year":"2018","journal-title":"Lancet Neurol"},{"key":"2025121501355960000_R27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/mdc3.12568","article-title":"Epidemiology of Parkinson\u2019s disease\u2014East versus west.","volume":"5","author":"Abbas","year":"2018","journal-title":"Mov Disord Clin Pract"},{"key":"2025121501355960000_R28","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1093\/ageing\/afp223","article-title":"Ageing, neurodegeneration and Parkinson\u2019s disease.","volume":"39","author":"Hindle","year":"2010","journal-title":"Age Ageing"},{"key":"2025121501355960000_R29","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.amepre.2014.05.017","article-title":"Public Health Spending and Population Health: A Systematic Review.","volume":"47","author":"Singh","year":"2014","journal-title":"Am J Prev Med"},{"key":"2025121501355960000_R30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l6326","article-title":"Performance of UK National Health Service compared with other high income countries: observational study.","volume":"367","author":"Papanicolas","year":"2019","journal-title":"BMJ"},{"key":"2025121501355960000_R31"},{"key":"2025121501355960000_R32","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/archneurol.2010.260","article-title":"Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues.","volume":"68","author":"Bronstein","year":"2011","journal-title":"Arch Neurol"},{"key":"2025121501355960000_R33"},{"key":"2025121501355960000_R34","doi-asserted-by":"publisher","DOI":"10.14802\/jmd.15043","article-title":"The current status of deep brain stimulation for the treatment of Parkinson\u2019s disease in the Republic of Korea.","volume":"8","author":"Lee","year":"2015","journal-title":"J Mov Disord"},{"key":"2025121501355960000_R35","doi-asserted-by":"publisher","first-page":"619","DOI":"10.4045\/tidsskr.16.0711","article-title":"Use of advanced therapies for Parkinson\u2019s disease in Norway.","volume":"137","author":"Ezat","year":"2017","journal-title":"Tidsskr Nor Laegeforen"},{"key":"2025121501355960000_R36"},{"key":"2025121501355960000_R37","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1177\/0306312713483678","article-title":"A history of deep brain stimulation: Technological innovation and the role of clinical assessment tools.","volume":"43","author":"Gardner","year":"2013","journal-title":"Soc Stud Sci"},{"key":"2025121501355960000_R38"},{"key":"2025121501355960000_R39"},{"key":"2025121501355960000_R40"},{"key":"2025121501355960000_R41"},{"key":"2025121501355960000_R42"},{"key":"2025121501355960000_R43","doi-asserted-by":"publisher","first-page":"e314","DOI":"10.1016\/j.wneu.2018.02.023","article-title":"Movement Disorders and Deep Brain Stimulation in the Middle East.","volume":"113","author":"Siddiqui","year":"2018","journal-title":"World Neurosurg"},{"key":"2025121501355960000_R44","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00314","article-title":"Deep brain stimulation programming 2.0: future perspectives for target identification and adaptive closed loop stimulation.","volume":"10","author":"Hell","year":"2019","journal-title":"Front Neurol"},{"key":"2025121501355960000_R45","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/mds.27228","article-title":"The changing landscape of surgery for Parkinson\u2019s Disease.","volume":"33","author":"Lozano","year":"2018","journal-title":"Mov Disord"},{"key":"2025121501355960000_R46","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2020.00162","article-title":"An International Survey of Deep Brain Stimulation Utilization in Asia and Oceania: The DBS Think Tank East.","volume":"14","author":"Zhang","year":"2020","journal-title":"Front Hum Neurosci"}],"container-title":["Australian Health Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/connectsci.au\/ah\/article-pdf\/48\/5\/497\/579586\/ah24036.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/connectsci.au\/ah\/article-pdf\/48\/5\/497\/579586\/ah24036.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:36:02Z","timestamp":1765780562000},"score":1,"resource":{"primary":{"URL":"https:\/\/connectsci.au\/ah\/article\/48\/5\/497\/81214\/The-treatment-gap-for-deep-brain-stimulation-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10,3]]}},"URL":"https:\/\/doi.org\/10.1071\/ah24036","relation":{},"ISSN":["0156-5788","1449-8944"],"issn-type":[{"value":"0156-5788","type":"print"},{"value":"1449-8944","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,16]]}}}